Misappropriation of Trade Secrets
The plaintiff, an East Coast biotechnology company, alleged that it developed a patented process for manufacturing specific biopharmaceutical therapies. They asserted that the defendant company developed a similar process and by doing so misappropriated trade secrets, engaged in unfair competition, false advertising and interference with a business relationship. After a four-month trial in federal court, the jury awarded the plaintiff several million dollars. The defendant filed numerous post-trial motions and eventually the judge overturned the jury verdict. The plaintiff filed an appeal that was denied. Defense costs were more than $2 million.